BACKGROUND: Expression of multiple graft-protective proteins targeted to different locations (i.e., intracellular, cell surface, and secreted) has become an increasingly important goal in xenotransplantation. The 2A "ribosome skip" signal is used as a linker to enable transgene co-expression, but some studies have shown that post-translational modification and trafficking of 2A-linked proteins may be adversely affected depending on their position relative to 2A. We tested whether several relevant proteins, subject to a range of processing and localization mechanisms, could be efficiently co-expressed using the 2A system. METHODS: Six expression cassettes were constructed, each containing up to four 2A-linked open reading frames, encoding combinations of human CD55, thrombomodulin (TBM), CD39, CTLA4-Ig and hygromycin resistance. Each linker incorporated a furin cleavage site to remove the carboxy-terminal extension that remains on upstream proteins after 2A processing. The cassettes were used to produce vectors for transfection, adenoviral transduction and transgenesis. Expression was detected by flow cytometry and/or Western blotting. RESULTS: All proteins were expressed in the appropriate location following transient transfection of COS-7 cells, irrespective of the number of linked genes. The percentage of stable transfectants expressing a linked gene was increased 10-fold (from 4-5% to 58-67%) by incorporating the hygromycin resistance gene into the cassette. Stable transfection of transgenic GalT KO pig fibroblasts with a hygromycin- TBM-CD39 construct resulted in surface expression of both TBM and CD39 by the majority of hygromycin-resistant cells. Expression was maintained after flow cytometric sorting and expansion. Adenoviral transduction of NIT-1 mouse insulinoma cells with a TBM-CD39 construct resulted in strong expression of both genes on the cell surface. Mice transgenic for 3-gene (CD55- TBM-CD39) or 4-gene (CD55- TBM-CTLA4Ig-CD39) constructs expressed all genes except CD55. CONCLUSIONS: These results confirm the versatility of the 2A system, and demonstrate that careful construct design can minimize potential problems with post-translational modification and trafficking. In addition, incorporation of a selection marker into the 2A-linked chain can dramatically increase the proportion of stable transfectants expressing proteins of interest. This provides a powerful method for the rapid modification of existing genetically modified pigs.
BACKGROUND: Expression of multiple graft-protective proteins targeted to different locations (i.e., intracellular, cell surface, and secreted) has become an increasingly important goal in xenotransplantation. The 2A "ribosome skip" signal is used as a linker to enable transgene co-expression, but some studies have shown that post-translational modification and trafficking of 2A-linked proteins may be adversely affected depending on their position relative to 2A. We tested whether several relevant proteins, subject to a range of processing and localization mechanisms, could be efficiently co-expressed using the 2A system. METHODS: Six expression cassettes were constructed, each containing up to four 2A-linked open reading frames, encoding combinations of humanCD55, thrombomodulin (TBM), CD39, CTLA4-Ig and hygromycin resistance. Each linker incorporated a furin cleavage site to remove the carboxy-terminal extension that remains on upstream proteins after 2A processing. The cassettes were used to produce vectors for transfection, adenoviral transduction and transgenesis. Expression was detected by flow cytometry and/or Western blotting. RESULTS: All proteins were expressed in the appropriate location following transient transfection of COS-7 cells, irrespective of the number of linked genes. The percentage of stable transfectants expressing a linked gene was increased 10-fold (from 4-5% to 58-67%) by incorporating the hygromycin resistance gene into the cassette. Stable transfection of transgenicGalT KO pig fibroblasts with a hygromycin- TBM-CD39 construct resulted in surface expression of both TBM and CD39 by the majority of hygromycin-resistant cells. Expression was maintained after flow cytometric sorting and expansion. Adenoviral transduction of NIT-1mouseinsulinoma cells with a TBM-CD39 construct resulted in strong expression of both genes on the cell surface. Micetransgenic for 3-gene (CD55- TBM-CD39) or 4-gene (CD55- TBM-CTLA4Ig-CD39) constructs expressed all genes except CD55. CONCLUSIONS: These results confirm the versatility of the 2A system, and demonstrate that careful construct design can minimize potential problems with post-translational modification and trafficking. In addition, incorporation of a selection marker into the 2A-linked chain can dramatically increase the proportion of stable transfectants expressing proteins of interest. This provides a powerful method for the rapid modification of existing genetically modified pigs.
Authors: Birgit Eisenhaber; Sebastian Maurer-Stroh; Maria Novatchkova; Georg Schneider; Frank Eisenhaber Journal: Bioessays Date: 2003-04 Impact factor: 4.345
Authors: J B Lorens; D M Pearsall; S E Swift; B Peelle; R Armstrong; S D Demo; D A Ferrick; Y Hitoshi; D G Payan; D Anderson Journal: J Biochem Biophys Methods Date: 2004-02-27
Authors: Johannes Lengler; Harry Holzmüller; Brian Salmons; Walter H Günzburg; Matthias Renner Journal: Anal Biochem Date: 2005-08-01 Impact factor: 3.365
Authors: P J Cowan; A Aminian; H Barlow; A A Brown; C G Chen; N Fisicaro; D M Francis; D J Goodman; W Han; M Kurek; M B Nottle; M J Pearse; E Salvaris; T A Shinkel; G V Stainsby; A B Stewart; A J d'Apice Journal: Transplantation Date: 2000-06-27 Impact factor: 4.939
Authors: Sarah L Londrigan; Robyn M Sutherland; Jamie L Brady; Emma M Carrington; Peter J Cowan; Anthony J F d'Apice; Philip J O'Connell; Yifan Zhan; Andrew M Lew Journal: Transplantation Date: 2010-11-15 Impact factor: 4.939
Authors: Sarah L Londrigan; Robyn M Sutherland; Jamie L Brady; Yifan Zhan; Ruili Li; Eugene Estella; Thomas W H Kay; Andrew M Lew Journal: J Gene Med Date: 2006-01 Impact factor: 4.565
Authors: S Crikis; X M Zhang; S Dezfouli; K M Dwyer; L M Murray-Segal; E Salvaris; C Selan; S C Robson; H H Nandurkar; P J Cowan; A J F d'Apice Journal: Am J Transplant Date: 2010-01-06 Impact factor: 8.086
Authors: Bryce W Carey; Styliani Markoulaki; Jacob Hanna; Kris Saha; Qing Gao; Maisam Mitalipova; Rudolf Jaenisch Journal: Proc Natl Acad Sci U S A Date: 2008-12-24 Impact factor: 11.205
Authors: Andrea L Szymczak; Creg J Workman; Yao Wang; Kate M Vignali; Smaroula Dilioglou; Elio F Vanin; Dario A A Vignali Journal: Nat Biotechnol Date: 2004-04-04 Impact factor: 54.908
Authors: E E Garanina; Y O Mukhamedshina; I I Salafutdinov; A P Kiyasov; L M Lima; H J Reis; A Palotás; R R Islamov; A A Rizvanov Journal: Spinal Cord Date: 2015-10-06 Impact factor: 2.772
Authors: Geon A Kim; Eun Mi Lee; Bumrae Cho; Zahid Alam; Su Jin Kim; Sanghoon Lee; Hyun Ju Oh; Jong Ik Hwang; Curie Ahn; Byeong Chun Lee Journal: Transgenic Res Date: 2018-12-14 Impact factor: 2.788
Authors: David K C Cooper; Burcin Ekser; Christopher Burlak; Mohamed Ezzelarab; Hidetaka Hara; Leela Paris; A Joseph Tector; Carol Phelps; Agnes M Azimzadeh; David Ayares; Simon C Robson; Richard N Pierson Journal: Xenotransplantation Date: 2012 May-Jun Impact factor: 3.907
Authors: Sol Ji Park; Bumrae Cho; Ok Jae Koo; Hwajung Kim; Jung Taek Kang; Sunghoon Hurh; Su Jin Kim; Hye Jung Yeom; Joonho Moon; Eun Mi Lee; Ji Yei Choi; Ju Ho Hong; Goo Jang; Joing-Ik Hwang; Jaeseok Yang; Byeong Chun Lee; Curie Ahn Journal: Transgenic Res Date: 2014-02-05 Impact factor: 2.788
Authors: Dilara Z Gatina; Ekaterina E Garanina; Margarita N Zhuravleva; Gulnaz E Synbulatova; Adelya F Mullakhmetova; Valeriya V Solovyeva; Andrey P Kiyasov; Catrin S Rutland; Albert A Rizvanov; Ilnur I Salafutdinov Journal: Int J Mol Sci Date: 2021-05-31 Impact factor: 5.923